Flucelvax
Seqirus secures first cell-based quadrivalent influenza vaccine approval in Europe
January 14, 2019Sales and Marketing Europe, Flucelvax, flu, influenza, pharma, seqirus
Seqirus has made it known that its new cell-based seasonal influenza vaccine Flucelvax Tetra has been approved by the European …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
